Ocular infections caused by non-tuberculous mycobacteria: Update on epidemiology and management

Clinical and Experimental Ophthalmology

Volumn 40, Issue 5, 2012, Pages 467-475

  Girgis, Dalia O ^a   Karp, Carol L ^a   Miller, Darlene ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Antibiotic; Bacterial disease; Eye; Fluoroquinolone; Infection

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE; ANTIBIOTIC AGENT; BIOMATERIAL; CLARITHROMYCIN; ERYTHROMYCIN; GATIFLOXACIN; LINEZOLID; MOXIFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; STEROID; ANTIINFECTIVE AGENT; HETEROCYCLIC COMPOUND; QUINOLINE DERIVATIVE;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ANTIBIOTIC SENSITIVITY; ATYPICAL MYCOBACTERIUM; BACTERIAL EYE INFECTION; BACTERIUM ISOLATE; CHILD; DRUG EXPOSURE; EARLY DIAGNOSIS; EYE SURGERY; FEMALE; HUMAN; INCIDENCE; INFECTION SENSITIVITY; KERATITIS; MAJOR CLINICAL STUDY; MALE; MYCOBACTERIUM ABSCESSUS; MYCOBACTERIUM CHELONAE; ORBIT INFECTION; REVIEW; RISK FACTOR; SEX RATIO; TREATMENT OUTCOME; ARTICLE; ATYPICAL MYCOBACTERIOSIS; CORNEA ULCER; ISOLATION AND PURIFICATION; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; PRESCHOOL CHILD; RETROSPECTIVE STUDY; SURGICAL INFECTION; UNITED STATES;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AMIKACIN; ANTI-BACTERIAL AGENTS; AZA COMPOUNDS; CHILD; CHILD, PRESCHOOL; CLARITHROMYCIN; COMBINED MODALITY THERAPY; CORNEAL ULCER; EYE INFECTIONS, BACTERIAL; FEMALE; FLORIDA; HUMANS; INCIDENCE; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; MYCOBACTERIUM INFECTIONS, NONTUBERCULOUS; NONTUBERCULOUS MYCOBACTERIA; OPHTHALMOLOGIC SURGICAL PROCEDURES; QUINOLINES; RETROSPECTIVE STUDIES; RISK FACTORS; SURGICAL WOUND INFECTION; YOUNG ADULT;

EID: 80155139624     PISSN: 14426404     EISSN: 14429071     Source Type: Journal    
DOI: 10.1111/j.1442-9071.2011.02679.x     Document Type: Review

References (50)

1. De la Cruz J, Pineda R. LASIK-associated atypical mycobacteria keratitis: a case report and review of the literature. Int Ophthalmol Clin 2007; 47: 73-84.
2. Covert TC, Rodgers MR, Reyes AL, Stelma GN. Occurrence of nontuberculous mycobacteria in environmental samples. Appl Environ Microbiol 1999; 65: 2492-6.
3. Carson LA, Peterson NJ, Favero MS, Aguero SM. Growth characteristics of atypical mycobacteria in water and their comparative resistance to disinfectants. Appl Environ Microbiol 1978; 36: 839-46.
4. Panwalker AP, Fuhse E. Nosocomial Mycobacterium gordonae pseudoinfection from contaminated ice machines. Infect Control 1986; 7: 67-70.
5. Falkinham JO. Epidemiology of infection by nontuberculous mycobacteria. Clin Microbiol Rev 1996; 9: 177-215.
6. O’Brien TP, Matoba AY. Nontuberculous mycobacterial diseases. In: Pepose JS, Holland GN, Wilhelmus KR, eds. Ocular Infection and Immunity. St. Louis, MO: Mosby, 1996; 1033-41.
7. Palani D, Kulandai LT, Naraharirao MH, Guruswami S, Ramendra B. Application of polymerase chain reaction-based restriction fragment length polymorphism in typing ocular rapid-growing nontuberculous mycobacterial isolates from three patients with postoperative endophthalmitis. Cornea 2007; 26: 729-35.
8. September SM, Brozel VS, Venter SN. Diversity of nontuberculoid Mycobacterium species in biofilms of urban and semiurban drinking water distribution systems. Appl Environ Microbiol 2004; 70: 7571-3.
9. Petrini B. Mycobacterium abscessus: an emerging rapidgrowing potential pathogen. APMIS 2006; 114: 319-28.
10. Ford JG, Huang AJ, Pflugfelder SC et al. Nontuberculous mycobacterial keratitis in south Florida. Ophthalmology 1998; 105: 1652-8.
11. Reviglio V, Rodriguez ML, Picotti GS et al. Mycobacterium chelonae keratitis following in situ keratomileusis. J Refract Surg 1998; 14: 357-60.
12. Solomon R, Donnenfeld ED, Azar DT et al. Infectious keratitis after laser in situ keratomileusis: results of an ASCRS survey. J Cataract Refract Surg 2003; 29: 2001-6.
13. Bottone EJ, Cho KW. Mycobacterium chelonae keratitis: elucidation of diagnosis through evaluation of smears of fluid from patient’s contact lens care system. Cornea 2005; 24: 356-8.
14. Srinivasan M, Prajna L, Prajna NV. A cluster of cases of Mycobacterium chelonei keratitis following penetrating keratoplasty. Indian J Ophthalmol 2005; 53: 67-8.
15. Chang MA, Jain S, Azar DT. Infections following laser in situ keratomileusis: an integration of the published literature. Surv Ophthalmol 2004; 49: 269-80.
16. Karp CL, Tuli SS, Yoo SH et al. Infectious keratitis after LASIK. Ophthalmology 2003; 110: 503-10.
17. Solomon A, Karp CL, Miller D et al. Mycobacterium interface keratitis after laser in situ keratomileusis. Ophthalmology 2001; 108: 2201-8.
18. Giaconi J, Pham R, Ta C. Bilateral Mycobacterium abscessus keratitis after laser in situ keratomileusis. J Cataract Refract Surg 2002; 28: 887-90.
19. Freitas D, Alvarenga L, Sampaio J et al. An outbeak of Mycobacterium chelonae infection after LASIK. Ophthalmology 2003; 110: 276-85.
20. Brancato R, Carones F, Venturi E, Cavallero A, Gesu G. Mycobacterium chelonae after excimer laser photorefractive keratectomy. Arch Ophthalmol 1997; 115: 1316-18.
21. Robin JB, Beatty RF, Dunn S et al. Mycobacterium chelonei keratitis after radial keratotomy. Am J Ophthalmol 1986; 102: 72-9.
22. Holland SP, Pulido JS, Miller D et al. Biofilm and scleral buckle-associated infections. A mechanism for persistence. Ophthalmology 1991; 98: 933-8.
23. Smiddy WE, Miller D, Flynn HW Jr. Scleral buckle infections due to atypical mycobacteria. Retina 1991; 11: 394-8.
24. Rootman DS, Insler MS, Wolley DE. Canaliculitis caused by Mycobacterium chelonae after lacrimal intubation with silicone tubes. Can J Ophthalmol 1989; 24: 221-2.
25. Ramaswamy AA, Biswas J, Bhaskar V et al. Postoperative Mycobacterium chelonae endophthalmitis after extracapsular cataract extraction and posterior chamber intraocular lens implantation. Ophthalmology 2000; 107: 1283-6.
26. Mutyala S, Dieckert JP, Papasian CJ. Mycobacterium fortuitum endophthalmitis. Retina 1996; 16: 122-4.
27. Margo C, Pavan PR. Mycobacterium chelonae conjunctivitis and scleritis following vitrectomy. Arch Ophthalmol 2000; 118: 1125-8.
28. Merani R, Orekondy S, Gottlieb T et al. Postoperative Mycobacterium abscessus nodular conjunctivitis. Clin Experiment Ophthalmol 2008; 36: 371-3.
29. Katowitz JA, Kropp TM. Mycobacterium fortuitum as a cause for nasolacrimal duct obstruction and granulomatous eyelid disease. Ophthalmic Surg 1987; 18: 97-9.
30. Moorthy RS, Rao NA. Atypical mycobacterial wound infection after blepharoplasty. Br J Ophthalmol 1995; 79: 93.
31. Smith RE, Salz JJ, Moors R, Silverstein D, Lewis W. Mycobacterium chelonei and orbital granuloma after tear duct probing. Am J Ophthalmol 1980; 89: 139-41.
32. Artenstein AW, Eiseman AS, Campbell GC. Chronic dacrocystitis caused by Mycobacterium fortuitum. Ophthalmology 1993; 100: 666-8.
33. Hamam RN, Nouredin B, Salti HI et al. Recalcitrant post-LASIK Mycobacterium chelonae keratitis eradicated after the use of fourth-generation fluoroquinolone. Ophthalmology 2006; 113: 950-4.
34. Lee SB, Oliver KM, Mohan SK et al. Fourth-generation fluoroquinolones in the treatment of mycobacterial infectious keratitis after laser-assisted in situ keratomileusis surgery. Can J Ophthalmol 2005; 40: 750-3.
35. Yakrus MA, Hernandez SM, Floyd MM et al. Comparison of methods for identification of Mycobacterium abscessus and M. chelonae isolates. J Clin Microbiol 2001; 39: 4103-10.
36. Tortoli E. Impact of genotypic studies on mycobacterial taxonomy: the new Mycobacteria of the 1990s. Clin Microbiol Rev 2003; 16: 319-54.
37. Daines BS, Vroman DT, Sandoval HP et al. Rapid diagnosis and treatment of mycobacterial keratitis after laser in situ keratomileusis. J Cataract Refract Surg 2003; 29: 1014-18.
38. Paschal JF, Holland GN, Sison RF et al. Mycobacterium fortuitum keratitis: clinicopathologic correlates and corticosteroid effects in an animal model. Cornea 1992; 11: 493-9.
39. Schulze-Robbecke R, Janning B, Fischeder R. Occurrence of mycobacteria in biofilm samples. Tuber Lung Dis 1992; 73: 141-4.
40. Ormerod LD, Ruoff KL, Meisler DM et al. Infectious crystalline keratopathy. Role of nutritionally variant streptococci and other bacterial factors. Ophthalmology 1991; 98: 159-69.
41. Murray PR, ed in chief. Manual of Clinical Microbiology, 7th edn. Washington, D.C.: ASM Press, 1999.
42. Serra C, Loi G, Saddi B, Pautasso M, Manzan A. Unusual clinical presentation of Mycobacterium fortuitum infection in an immunocompetent woman. J Clin Microbiol 2007; 45: 1663-5.
43. Eiferman RA, Stagner JI. Intraocular penetration of amikacin. Iris binding and bioavailability. Arch Ophthalmol 1982; 100: 1817-19.
44. Kuehne JJ, Yu AL, Holland G et al. Corneal pharmokinetics of topically applied azithromycin and clarithromycin. Am J Ophthalmol 2004; 138: 547-53.
45. de la Cruz J, Behlau I, Pineda R. Atypical mycobacteria keratitis after laser in situ keratomileusis unresponsive to fourth-generation fluoroquinolone therapy. J Cataract Refract Surg 2007; 33: 1318-21.
46. Moshirfar M, Meyer JJ, Espandar L. Fourthgeneration fluoroquinolone-resistant mycobacterial keratitis after laser in situ keratomileusis. J Cataract Refract Surg 2007; 33: 1978-81.
47. Alexandrakis G, Alfonso EC, Miller D. Shifting trends in bacterial keratitis in south Florida and emerging resistance to fluoroquinolones. Ophthalmology 2000; 107: 1497-502.
48. Kovoor TA, Kim AS, McCulley JP et al. Evaluation of the corneal effects of topical ophthalmic fluoroquinolones using in vivo confocal microscopy. Eye Contact Lens 2004; 30: 90-4.
49. Wallace RJ, Brown-Elliot BA, Crist CJ et al. Activities of linezolid against rapidly growing mycobacteria. Antimicrob Agents Chemother 2001; 45: 764-7.
50. Joshi L, Taylor SR, Large O et al. A case of optic neuropathy after short term linezolid use in a patient with acute lymphocytic leukemia. Clin Infect Dis 2009; 48: e73-4.